<div id="readability-page-1">03:55 PM EST, 12/18/2025 (MT Newswires) -- Health care stocks rose late Thursday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 0.3%.The iShares Biotechnology ETF (IBB) fell 0.8%.In corporate news, AbCellera Biologics ( ABCL ) shares gained 5.2%. The company will receive $36 million upfront from Bruker (BRKR) as part of a patent litigation settlement.Irenic Capital Management has built a stake of more than 3% in Integer (ITGR) and is calling on the company to revamp its board and consider a sale as its shares trade at a discount, The Wall Street Journal reported. Integer shares climbed 5.6%.Eli Lilly ( LLY ) will reduce the prices of its diabetes and weight-loss drugs Mounjaro and Zepbound by 20% or more in Canada from Dec. 29, The Globe and Mail reported Thursday, citing a note to pharmacies Wednesday night. Eli Lilly ( LLY ) shares rose 1.8%.Athira Pharma ( ATHA ) shares surged about 66% after it disclosed Thursday that it agreed to acquire the rights for the development and commercialization of lasofoxifene to treat breast cancer. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

Integer控股

礼来

ABCL

医疗保健股票在周四下午晚些时候上涨，纽约证券交易所医疗保健指数和 State Street 医疗保健精选行业 SPDR ETF 均上涨了 0.3%。由于达成 3600 万美元的和解，AbCellera Biologics 的股票上涨了 5.2%。Integer 的股票上涨了 5.6%，因为 Irenic Capital Management 增持股份并呼吁董事会进行变更。礼来的股票在宣布在加拿大降价后上涨了 1.8%。Athira Pharma 的股票在获得乳腺癌治疗权利后飙升了 66%

板块更新：医疗保健类股票在下午晚些时候上涨